Evidence map›Paper›PMID 37280209›Full record

ArticleNature communications2023

Copper-catalyzed asymmetric C(sp

Rupeng Qi, Qiao Chen, Liangyu Liu, Zijian Ma, Da Pan, Hongying Wang, Zhixuan Li, Chao Wang, Zhaoqing Xu

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Computational Experiments Probing the Adaptability of the [NCCHChemphyschem : a European journal of chemical physics and physical chemistry · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Rupeng Qi *School of Pharmacy, Lanzhou University, 730000, Lanzhou, China.
Qiao Chen *School of Pharmacy, Lanzhou University, 730000, Lanzhou, China.
Liangyu Liu *Key Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Lanzhou University, 730000, Lanzhou, China.
Zijian MaKey Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Lanzhou University, 730000, Lanzhou, China.
Da PanSchool of Pharmacy, Lanzhou University, 730000, Lanzhou, China.
Hongying WangKey Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Lanzhou University, 730000, Lanzhou, China.
Zhixuan LiKey Laboratory of Preclinical Study for New Drugs of Gansu Province, School of Basic Medical Sciences, Lanzhou University, 730000, Lanzhou, China.
Chao WangResearch Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, 730000, Lanzhou, China. wangchao@lzu.edu.cn.ORCID 0000-0001-9235-1243
Zhaoqing XuResearch Unit of Peptide Science, Chinese Academy of Medical Sciences, 2019RU066, 730000, Lanzhou, China. zqxu@lzu.edu.cn.ORCID 0000-0001-7663-6249
Lanzhou University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alkylnitriles play important roles in many fields because of their unique electronic properties and structural characteristics. Incorporating cyanoalkyl with characteristic spectroscopy and reactivity properties into amino acids and peptides is of special interest for potential imaging and therapeutic purposes. Here, we report a copper-catalyzed asymmetric cyanoalkylation of C(sp

Indexed as

CopperGlycineCatalysisEstersMolecular StructurePeptidesCopperEstersGlycinePeptides

Identifiers

PMID37280209
PMCPMC10244411
OpenAlexW4379600211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.